LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 128 filers reported holding LEXICON PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.94 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $5,000 | +25.0% | 500 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $4,000 | -20.0% | 500 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $5,000 | -50.0% | 500 | -37.5% | 0.00% | -66.7% |
| Q3 2017 | $10,000 | -23.1% | 800 | 0.0% | 0.00% | -25.0% |
| Q2 2017 | $13,000 | +18.2% | 800 | 0.0% | 0.00% | +33.3% |
| Q1 2017 | $11,000 | 0.0% | 800 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $11,000 | -21.4% | 800 | 0.0% | 0.00% | -25.0% |
| Q3 2016 | $14,000 | 0.0% | 800 | -17.9% | 0.00% | -20.0% |
| Q2 2016 | $14,000 | +250.0% | 975 | +225.0% | 0.01% | +150.0% |
| Q1 2016 | $4,000 | +33.3% | 300 | 0.0% | 0.00% | +100.0% |
| Q3 2015 | $3,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $25,366,000 | 100.00% |
| Artal Group S.A. | 71,178,364 | $417,817,000 | 7.38% |
| BVF INC/IL | 8,394,000 | $49,273,000 | 1.85% |
| Boothe Investment Group, Inc. | 435,939 | $2,559,000 | 1.49% |
| Campbell & CO Investment Adviser LLC | 103,100 | $605,000 | 0.37% |
| NEA Management Company, LLC | 2,382,286 | $13,984,000 | 0.31% |
| PINNACLE ASSOCIATES LTD | 2,167,172 | $12,721,000 | 0.24% |
| Eversept Partners, LP | 410,593 | $2,410,181 | 0.18% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $210,000 | 0.12% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 66,299 | $389,000 | 0.08% |